Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-12

Clinical Trial Update: Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating ACT-based group self-management for Type 1 diabetes was withdrawn before completion, with no reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: WITHDRAWN